Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

Shi-Yi Lyu,Wang Xiao,Guang-Zu Cui,Cheng Yu,Huan Liu,Min Lyu,Qian-Ya Kuang,En-Hua Xiao,Yong-Heng Luo

DOI: https://doi.org/10.3389/fgene.2023.1265506

IF: 3.7

2023-08-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2023.1124330.].

genetics & heredity

What problem does this paper attempt to address?

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Ke Meng,Huacong Cai,Simin Cai,Yucai Hong,X Zhang

DOI: https://doi.org/10.3389/fcell.2023.997572

IF: 5.5

2023-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.644160.].
Corrigendum: RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Yang Xiang,Benoit Laurent,Chih-Hung Hsu,Sigrid Nachtergaele,Zhike Lu,Wanqiang Sheng,Chuanyun Xu,Hao Chen,Jian Ouyang,Siqing Wang,Dominic Ling,Pang-Hung Hsu,Lee Zou,Ashwini Jambhekar,Chuan He,Yang Shi

DOI: https://doi.org/10.1038/nature24007

IF: 64.8

2017-01-01

Nature

Abstract:This corrects the article DOI: 10.1038/nature21671.
Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Song Miao,Jie Lü,Weiqi Dai,Wei Fan,Ling Xu,Kan Chen,Lei He,Ping Cheng,Yan Zhang,Chengfen Wang,Dong Wu,Jing Yang,Rong Zhu,Huawei Zhang,Yingqun Zhou,Chuanyong Guo

DOI: https://doi.org/10.1155/2016/5434275

2016-01-01

Mediators of Inflammation

Abstract:[This corrects the article DOI: 10.1155/2013/461536.].
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Jie Wen,Abudureyimujiang Aili,Yao Xue Yan,YuLin Lai,Shaoqing Niu,Shasha He,Xiaokai Zhang,Guixiong Zhang,Jiaping Li

DOI: https://doi.org/10.3389/fonc.2022.1038279

IF: 4.7

2022-10-26

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.977348.].

oncology
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Correction to “Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation”

Qiu-Ming Wang,Jian-Ling Du,Zhi-Jun Duan,Shi-Bin Guo,Xiao-Yu Sun,Zhen Liu

DOI: https://doi.org/10.3748/wjg.v28.i35.5237

IF: 5.374

2022-09-21

World Journal of Gastroenterology

Abstract:[This corrects the article on p. 2921 in vol. 19, PMID: 23704825.].

gastroenterology & hepatology
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Yong-Zheng Zhang,Amir Zeb,Lu-Feng Cheng

DOI: https://doi.org/10.3389/fimmu.2023.1168774

IF: 7.3

2023-02-28

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1032819.].

immunology
Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis

Bing Yang,Liqing Lu,Dongmei Zhou,Wei Fan,Lucía Barbier-Torres,Justin Steggerda,Heping Yang,Xi Yang

DOI: https://doi.org/10.3389/fendo.2023.1284809

IF: 6.055

2023-09-28

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2022.1007944.].

endocrinology & metabolism
Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

Mingming Fan,Huijuan Xiao,Dingyun Song,Lili Zhu,Jie Zhang,Xinran Zhang,Jing Wang,Huaping Dai,Chen Wang

DOI: https://doi.org/10.3389/fphar.2022.1109002

IF: 5.6

2023-01-18

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.848435.].

pharmacology & pharmacy
Corrigendum to ‘therapeutic HNF4A Mrna Attenuates Liver Fibrosis in a Preclinical Model’ [J Hepatol (2021) 1420-1433]

Taihua Yang,Marion Poenisch,Rajendra Khanal,Qingluan Hu,Zhen Dai,Ruomeng Li,Guangqi Song,Qinggong Yuan,Qunyan Yao,Xizhong Shen,Richard Taubert,Bastian Engel,Elmar Jaeckel,Arndt Vogel,Christine S Falk,Axel Schambach,Daniela Gerovska,Marcos J Araúzo-Bravo,Florian W R Vondran,Tobias Cantz,Nigel Horscroft,Asha Balakrishnan,Frédéric Chevessier,Michael Ott,Amar Deep Sharma

DOI: https://doi.org/10.1016/j.jhep.2022.03.023

IF: 25.7

2022-01-01

Journal of Hepatology

Abstract:It has come to our attention that in the financial support statement, we erroneously acknowledged funding support from the PLUS3 programme of Boehringer Ingelheim. Funding support was actually received from the PLUS3 programme of the Boehringer Ingelheim foundation (an independent non-profit foundation). We apologise for any inconvenience caused.
Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo

Dan Tang,Ruo-Yu Wang,Ke-Wei Sun,Yunan Wu,Lin Ding,Yang Mo

DOI: https://doi.org/10.3389/fphar.2022.1105804

IF: 5.6

2022-12-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1003479.].

pharmacology & pharmacy
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Jinbiao He,Yu Yang,Fan Zhang,Yanjuan Li,Xiaosi Li,Xuemei Pu,Xudong He,Mei Zhang,Xinxing Yang,Qiuman Yu,Yan Qi,Xuefang Li,Jie Yu

DOI: https://doi.org/10.3389/fphar.2023.1172950

IF: 5.6

2023-05-19

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1007274.].

pharmacology & pharmacy
Correction To: DNMT3A Reads and Connects Histone H3K36me2 to DNA Methylation

Wenqi Xu,Jiahui Li,Bowen Rong,Bin Zhao,Mei Wang,Ruofei Dai,Qilong Chen,Hang Liu,Zhongkai Gu,Shuxian Liu,Rui Guo,Hongjie Shen,Feizhen Wu,Fei Lan

DOI: https://doi.org/10.1007/s13238-019-00678-6

2019-01-01

Protein & Cell

Abstract:The author would like to add the below information in this correction. A similar study from Chao Lu group was published online on 5 September 2019 in Nature, entitled "The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape" (Weinberg et al., 2019). Although both the studies reported the preferential recognition of H3K36me2 by DNMT3A PWWP, ours in addition uncovered a stimulation function by such interaction on the activity of DNMT3A. On the disease connections, we used a NSD2 gain-of-function model which led to the discovery of potential therapeutic implication of DNA inhibitors in the related cancers, while the other study only used NSD1 and DNMT3A loss-of-function models.
Corrigendum: Single-cell RNA sequencing reveals the role of phosphorylation-related genes in hepatocellular carcinoma stem cells

Fuwen Yao,Yongqiang Zhan,Changzheng Li,Ying Lu,Jiao Chen,Jing Deng,Zijing Wu,Qi Li,Yi'an Song,Binhua Chen,Jinjun Chen,Kuifeng Tian,Zuhui Pu,Yong Ni,Lisha Mou

DOI: https://doi.org/10.3389/fcell.2023.1045260

2023-10-23

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.734287.].
Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

Zhan Jing-Lun,Chai Shuang,Zhao Li-Mei,Liu Xiao-Dong

DOI: https://doi.org/10.3389/fphar.2024.1395496

2024-08-15

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1205062.].
Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Tianyu Zhai,Xiaoyu Zhang,Zhenyu Hei,Longyang Jin,Chao Han,Audrey Tsznam Ko,Xiaofeng Yu,Jiandong Wang

DOI: https://doi.org/10.3389/fphar.2021.792330

IF: 5.6

2021-10-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.628621.].

pharmacology & pharmacy
Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

Yingying Liu,Yingying Tan,Jiaqi Huang,Chao Wu,Xiaotian Fan,Antony Stalin,Shan Lu,Haojia Wang,Jingyuan Zhang,Fanqin Zhang,Zhishan Wu,Bing Li,Zhihong Huang,Meilin Chen,Guoliang Cheng,Yanfang Mou,Jiarui Wu

DOI: https://doi.org/10.3389/fphar.2023.1243304

IF: 5.6

2023-07-27

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.875700.].

pharmacology & pharmacy

Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Corrigendum: RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Correction to “Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation”

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

Corrigendum to ‘therapeutic HNF4A Mrna Attenuates Liver Fibrosis in a Preclinical Model’ [J Hepatol (2021) 1420-1433]

Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Correction To: DNMT3A Reads and Connects Histone H3K36me2 to DNA Methylation

Corrigendum: Single-cell RNA sequencing reveals the role of phosphorylation-related genes in hepatocellular carcinoma stem cells

Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology